View in EDS

A novel prognostic risk model for patients with refractory/relapsed acute myeloid leukemia receiving venetoclax plus hypomethylating agents.

Saved in:
Bibliographic Details
Title: A novel prognostic risk model for patients with refractory/relapsed acute myeloid leukemia receiving venetoclax plus hypomethylating agents.
Authors: Shahswar R; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Gabdoulline R; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Krueger K; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Wichmann M; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Götze KS; Department of Medicine III, Technical University of Munich (TUM) School of Medicine and Health, Munich, Germany.; Bavarian Center for Cancer Research (BZKF), Erlangen, Germany., Braitsch K; Department of Medicine III, Technical University of Munich (TUM) School of Medicine and Health, Munich, Germany., Meggendorfer M; MLL, Munich Leukemia Laboratory, Munich, Germany., Schmalbrock L; Department of Hematology, Oncology, and Tumor Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Bullinger L; Department of Hematology, Oncology, and Tumor Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Modemann F; Department of Oncology, Hematology and Bone Marrow Transplantation, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Fiedler W; Department of Oncology, Hematology and Bone Marrow Transplantation, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Krauter J; Department of Internal Medicine, Municipal Hospital Braunschweig, Braunschweig, Germany., Kaun S; Department of Internal Medicine, Municipal Hospital Bremen-Mitte, Bremen, Germany., Rotermund S; Department of Internal Medicine, Municipal Hospital Bremen-Mitte, Bremen, Germany., Voß A; Department of Oncology and Hematology, University Clinic Oldenburg, Oldenburg, Germany., Behrens YL; Department of Human Genetics, Hannover Medical School, Hannover, Germany., Bergmann AK; Department of Human Genetics, Hannover Medical School, Hannover, Germany., Koller E; 3rd Medical Department, Hanusch Hospital, Vienna, Austria., Beutel G; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Thol F; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Heidel F; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Heuser M; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany. innere4@uk-halle.de.; Department of Internal Medicine IV, University Hospital Halle (Saale), Martin-Luther-University Halle-Wittenberg, Halle, Germany. innere4@uk-halle.de.
Source: Leukemia [Leukemia] 2025 Mar; Vol. 39 (3), pp. 614-622. Date of Electronic Publication: 2025 Jan 08.
Publication Type: Journal Article; Multicenter Study; Observational Study
Journal Info: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39779979
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A novel prognostic risk model for patients with refractory/relapsed acute myeloid leukemia receiving venetoclax plus hypomethylating agents.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Shahswar+R%22">Shahswar R</searchLink>; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.<br /><searchLink fieldCode="AU" term="%22Gabdoulline+R%22">Gabdoulline R</searchLink>; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.<br /><searchLink fieldCode="AU" term="%22Krueger+K%22">Krueger K</searchLink>; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.<br /><searchLink fieldCode="AU" term="%22Wichmann+M%22">Wichmann M</searchLink>; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.<br /><searchLink fieldCode="AU" term="%22Götze+KS%22">Götze KS</searchLink>; Department of Medicine III, Technical University of Munich (TUM) School of Medicine and Health, Munich, Germany.; Bavarian Center for Cancer Research (BZKF), Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Braitsch+K%22">Braitsch K</searchLink>; Department of Medicine III, Technical University of Munich (TUM) School of Medicine and Health, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Meggendorfer+M%22">Meggendorfer M</searchLink>; MLL, Munich Leukemia Laboratory, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Schmalbrock+L%22">Schmalbrock L</searchLink>; Department of Hematology, Oncology, and Tumor Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Bullinger+L%22">Bullinger L</searchLink>; Department of Hematology, Oncology, and Tumor Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Modemann+F%22">Modemann F</searchLink>; Department of Oncology, Hematology and Bone Marrow Transplantation, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Fiedler+W%22">Fiedler W</searchLink>; Department of Oncology, Hematology and Bone Marrow Transplantation, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Krauter+J%22">Krauter J</searchLink>; Department of Internal Medicine, Municipal Hospital Braunschweig, Braunschweig, Germany.<br /><searchLink fieldCode="AU" term="%22Kaun+S%22">Kaun S</searchLink>; Department of Internal Medicine, Municipal Hospital Bremen-Mitte, Bremen, Germany.<br /><searchLink fieldCode="AU" term="%22Rotermund+S%22">Rotermund S</searchLink>; Department of Internal Medicine, Municipal Hospital Bremen-Mitte, Bremen, Germany.<br /><searchLink fieldCode="AU" term="%22Voß+A%22">Voß A</searchLink>; Department of Oncology and Hematology, University Clinic Oldenburg, Oldenburg, Germany.<br /><searchLink fieldCode="AU" term="%22Behrens+YL%22">Behrens YL</searchLink>; Department of Human Genetics, Hannover Medical School, Hannover, Germany.<br /><searchLink fieldCode="AU" term="%22Bergmann+AK%22">Bergmann AK</searchLink>; Department of Human Genetics, Hannover Medical School, Hannover, Germany.<br /><searchLink fieldCode="AU" term="%22Koller+E%22">Koller E</searchLink>; 3rd Medical Department, Hanusch Hospital, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Beutel+G%22">Beutel G</searchLink>; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.<br /><searchLink fieldCode="AU" term="%22Thol+F%22">Thol F</searchLink>; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.<br /><searchLink fieldCode="AU" term="%22Heidel+F%22">Heidel F</searchLink>; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.<br /><searchLink fieldCode="AU" term="%22Heuser+M%22">Heuser M</searchLink>; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany. innere4@uk-halle.de.; Department of Internal Medicine IV, University Hospital Halle (Saale), Martin-Luther-University Halle-Wittenberg, Halle, Germany. innere4@uk-halle.de.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228704895%22">Leukemia</searchLink> [Leukemia] 2025 Mar; Vol. 39 (3), pp. 614-622. <i>Date of Electronic Publication: </i>2025 Jan 08.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Multicenter Study; Observational Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%2C+Specialist+Journals%22">Nature Publishing Group, Specialist Journals </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8704895 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-5551 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2208876924%22">08876924 </searchLink><i>NLM ISO Abbreviation: </i>Leukemia <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39779979
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41375-024-02501-6
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 614
    Titles:
      – TitleFull: A novel prognostic risk model for patients with refractory/relapsed acute myeloid leukemia receiving venetoclax plus hypomethylating agents.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Shahswar R
      – PersonEntity:
          Name:
            NameFull: Gabdoulline R
      – PersonEntity:
          Name:
            NameFull: Krueger K
      – PersonEntity:
          Name:
            NameFull: Wichmann M
      – PersonEntity:
          Name:
            NameFull: Götze KS
      – PersonEntity:
          Name:
            NameFull: Braitsch K
      – PersonEntity:
          Name:
            NameFull: Meggendorfer M
      – PersonEntity:
          Name:
            NameFull: Schmalbrock L
      – PersonEntity:
          Name:
            NameFull: Bullinger L
      – PersonEntity:
          Name:
            NameFull: Modemann F
      – PersonEntity:
          Name:
            NameFull: Fiedler W
      – PersonEntity:
          Name:
            NameFull: Krauter J
      – PersonEntity:
          Name:
            NameFull: Kaun S
      – PersonEntity:
          Name:
            NameFull: Rotermund S
      – PersonEntity:
          Name:
            NameFull: Voß A
      – PersonEntity:
          Name:
            NameFull: Behrens YL
      – PersonEntity:
          Name:
            NameFull: Bergmann AK
      – PersonEntity:
          Name:
            NameFull: Koller E
      – PersonEntity:
          Name:
            NameFull: Beutel G
      – PersonEntity:
          Name:
            NameFull: Thol F
      – PersonEntity:
          Name:
            NameFull: Heidel F
      – PersonEntity:
          Name:
            NameFull: Heuser M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: 2025 Mar
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1476-5551
          Numbering:
            – Type: volume
              Value: 39
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Leukemia
              Type: main
ResultId 1